Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats

被引:0
作者
Xizhe Gao
Yi-Hua Sheng
Sijia Yu
Jiadong Li
Raymond Rosa
Simone Girgis
Tiffany Guo
Luigi Brunetti
Leonid Kagan
机构
[1] The State University of New Jersey,Department of Pharmaceutics, Ernest Mario, School of Pharmacy, Rutgers
[2] Ernest Mario School of Pharmacy,Center of Excellence for Pharmaceutical Translational Research and Education
[3] Rutgers,Comparative Medicine Resources, Rutgers
[4] The State University of New Jersey,Department of Pharmacy Practice and Administration, Ernest Mario, School of Pharmacy, Rutgers
[5] The State University of New Jersey,undefined
[6] The State University of New Jersey,undefined
来源
Pharmaceutical Research | 2023年 / 40卷
关键词
antibodies; biologics; drug delivery; modeling and simulation; obesity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1223 / 1238
页数:15
相关论文
共 145 条
[1]  
Bays HE(2011)Adiposopathy is "sick fat" a cardiovascular disease? J Am Coll Cardiol 57 2461-2473
[2]  
Bouchard C(2010)Defining the genetic architecture of the predisposition to obesity: a challenging but not insurmountable task Am J Clin Nutr 91 5-6
[3]  
Nguyen DM(2010)The epidemiology of obesity Gastroenterol Clin North Am 39 1-7
[4]  
El-Serag HB(2017)Drug dosing in obese adults Aust Prescr 40 189-193
[5]  
Barras M(2012)A guide to rational dosing of monoclonal antibodies Clin Pharmacokinet 51 119-135
[6]  
Legg A(2012)Clinical pharmacology considerations in biologics development Acta Pharmacol Sin 33 1339-1347
[7]  
Bai S(2008)Monoclonal antibody pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 84 548-558
[8]  
Jorga K(2018)Comparative biodistribution analysis across four different (89)Zr-monoclonal antibody tracers-The first step towards an imaging warehouse Theranostics 8 4295-4304
[9]  
Xin Y(2010)Effect of obesity on the pharmacokinetics of drugs in humans Clin Pharmacokinet 49 71-87
[10]  
Jin D(2015)The weight debate J Intensive Care Soc 16 234-238